O-103 Validating response and toxicity predictions of the ''virtual patient'' in neoadjuvant and adjuvant breast cancer chemotherapy

S. Ariad; S. Chan; Z. Agur

首页> 外文期刊>European Journal of Cancer Supplements >O-103 Validating response and toxicity predictions of the ''virtual patient'' in neoadjuvant and adjuvant breast cancer chemotherapy

【24h】

O-103 Validating response and toxicity predictions of the ''virtual patient'' in neoadjuvant and adjuvant breast cancer chemotherapy

机译：O-103验证“新患者”和“辅助乳腺癌”化疗中“虚拟患者”的反应和毒性预测

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2007年第3期|共2页
作者
S. Ariad; S. Chan; Z. Agur;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Prediction of response to repeat utilization of anthracycline in recurrent breast cancer patients previously administered anthracycline-containing chemotherapeutic regimens as neoadjuvant or adjuvant chemotherapy. [J] . Yonemori K, Katsumata N, Kaneko M, Breast cancer research and treatment. . 2007,第3期

机译：以前使用过含蒽环类化疗方案作为新辅助或辅助化疗的复发性乳腺癌患者，对重复使用蒽环类抗生素的反应预测。
2. Prediction of response to repeat utilization of anthracycline in recurrent breast cancer patients previously administered anthracycline-containing chemotherapeutic regimens as neoadjuvant or adjuvant chemotherapy [J] . Kan Yonemori, Noriyuki Katsumata, Masayuki Kaneko, Breast Cancer Research and Treatment . 2007,第3期

机译：以前使用含蒽环类化疗方案作为新辅助或辅助化疗的复发乳腺癌患者对重复使用蒽环类药物的反应的预测
3. Response to “Late relapse rates in patients with early‐stage hormone receptor positive and HER2+ breast cancer treated with adjuvant chemotherapy and neoadjuvant chemotherapy” [J] . Journal of Surgical Oncology . 2020,第6期

机译：反应“用佐剂化疗和新辅助化疗治疗的早期激素受体阳性和海绵体受体阳性患者患者的晚期复发率”
4. Breast MRI radiomics for the pre-treatment prediction of response to neoadjuvant chemotherapy in node-positive breast cancer patients [C] . Karen Drukker, Iman El-Bawab, Alexandra Edwards, SPIE Conference on Computer-Aided Diagnosis . 2019

机译：乳腺MRI辐射射清，用于节点阳性乳腺癌患者对新辅助化疗的反应预处理预测
5. Coregistration of serial breast MR studies for augmenting neoadjuvant chemotherapy response evaluation in breast cancer patients. [D] . Chittineni, Ruparani. 2008

机译：增强乳腺癌患者新系列辅助化疗反应评估的系列乳房MR研究的核心。
6. Prospective Validation of Immunological Infiltrate for Prediction of Response to Neoadjuvant Chemotherapy in HER2-Negative Breast Cancer – A Substudy of the Neoadjuvant GeparQuinto Trial [O] . Yasmin Issa-Nummer, Silvia Darb-Esfahani, Sibylle Loibl, -1

机译：免疫学浸润量预测HER2阴性乳腺癌对新辅助化疗反应的前瞻性验证– GeparQuinto新辅助试验的一项子研究
7. A nested cohort study of 6,248 early breast cancer patients treated in neoadjuvant and adjuvant chemotherapy trials investigating the prognostic value of chemotherapy-related toxicities [O] . Abraham Jean Elizabeth, Hiller Louise, Dorling Leila, 2016

机译：在新辅助和辅助化疗试验中对6,248例早期乳腺癌患者进行的嵌套队列研究，研究了与化疗相关的毒性的预后价值

O-103 Validating response and toxicity predictions of the ''virtual patient'' in neoadjuvant and adjuvant breast cancer chemotherapy

著录项

相似文献

相关主题

期刊订阅